Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
10/2003
10/21/2003US6635241 Applying aminophenol derivative to keratinous fiber as primary intermediate, oxidizing to color fiber
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084631A1 Apparatus and process used in growing crystals
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030194371 Nuclear magnetic resonance (NMR) diagnosis and radiotherapy
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/15/2003EP1351923A2 Antiperspirant salts for enhanced cosmetic products
10/15/2003EP1351922A2 6-substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP0907788B1 Process for the bleaching of chemical pulp
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/14/2003US6632950 By reducing the corresponding 4-nitro derivative; useful as monomers for polyamides capable of binding dsDNA (double stranded DNA) and hence in nucleotide sequence recognition
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003CA2028782C Process for the production of vinyl-gaba
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003050063A3 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE β-AMINO-ALCOHOLS
10/09/2003WO2003040439A3 A process for crystallising oxonorleucinacetal
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003WO2002008228A3 Method for the manufacture of anagrelide
10/09/2003US20030191306 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
10/09/2003US20030190298 Use as skin lightening agents
10/08/2003EP1349859A2 Triazolopyrimidines
10/08/2003EP1349828A1 Process for preparing isomers of salbutamol
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/08/2003CN1123562C Process for preparing R-(+)-N-(substituted phenyl) lactamic acid or its ester
10/07/2003US6630557 Tertiary amine methacrylate-based macromonomers and polymers
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/02/2003WO2003080562A1 Production of aminocrotonates
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003US20030187296 Alkenylation, hydrogenation by starting acetoxycyclopent-2-en-1-one compound, removing acetoxy group, to form 3-alkylcyclopentanone; chemical intermediates for the synthesis of gabapentin
10/02/2003US20030187249 Main-group metal-based asymmetric catalysts and applications thereof
10/02/2003US20030187147 Reacting a iminoester with polymer
10/02/2003US20030187041 Cardiovascular disorders
10/02/2003US20030182735 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
10/01/2003EP1348689A1 Process for production of s,s-ethylenediamine-n,n'-disuccinic acid iron alkali salt
10/01/2003EP1347951A1 A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP0973724B1 Novel process for the preparation of (+/-)3- (3,4-dichlorophenyl)-2- dimethylamino-2-methylpropan-1-ol or cericlamine (inn)
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
09/2003
09/30/2003US6627772 Reacting morpholinone with formaldehyde or hydrogen cyanide
09/30/2003US6627771 4-Amino-3-cyclopentylbutyric acid; antiepileptic, anxiolytic, antidepressant, analgesic, and antiinflammatory agents; brain, neurodegenerative, nervous system, psychological, and gastrointestinal disorders
09/30/2003US6626982 Compound storage
09/30/2003CA2108707C Esters of l-carnitine and alkanoyl l-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078381A1 PROCESS FOR PREPARATION OF trans-4-AMINOCYCLOHEXANE- CARBOXYLIC ACIDS
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003078358A2 Use of microfabricated devices for radiosynthesis
09/25/2003WO2003010128A3 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181688 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
09/25/2003US20030181523 Mono-and disubstituted 3-propyl gamma-aminobutyric acids
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/24/2003EP1346971A1 Production method for biarylalanine
09/24/2003EP1345952A2 Isolation of nucleic acids
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1140793B1 Process for the synthesis of 1-(aminomethyl)cyclohexyl-acetic acid
09/24/2003EP1090151B1 Process for separation of heavy metals from residues by use of of ethylenediamine-disuccinic acid (edds) complexant
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003CN1444591A Method for preparing chromium Ôàó organic complex, its use as corrosion inhibiting agent and as anticorrosive coating agent
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624327 Process for preparing betaines
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076393A1 Salts of nateglinide
09/18/2003WO2003076390A1 Yellow-emitting compounds, process for the production thereof, yellow-emitting devices and white-emitting devices
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003076072A1 Practical chiral zirconium catalyst
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2002102764A3 Method for producing chiral amino acid derivatives
09/18/2003US20030176735 Catalyzing the dehydrogenation, follow by cyanomethylation, hydrolysis; as intermediate materials for making N-(phosphonomethyl)glycine agricultural chemical
09/18/2003US20030176732 Process for the preparation of carboxylic acids from aliphatic alcohols
09/18/2003US20030176669 Process for obtaining bio-functional fractions from biomass
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030176489 Glyt-1 inhibitors
09/18/2003US20030176468 Reacting keto-vinyl ether compound with dialkylaminoacrylate compound to obtain dialkylamino-oxo-ester compound; reacting with ammonia or ammonium compound to form nicotinic ester compound, hydrolysis
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478599A1 Salts of nateglinide
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/17/2003CN1443159A Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/17/2003CN1121375C Oligosaccharide synthesis
09/17/2003CN1121215C Amino acid derivatives and active oxygen resisting agent
09/12/2003WO2003074470A1 PROCESS FOR PRODUCING tert-LEUCINE
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2002053518A3 HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 215